Fuensanta Moreno

TL;DR: An improvement in QOL indices was globally observed; this improvement was much more marked in men than in women, for unclear reasons, and older age and greater prior comorbidity diminished the beneficial effects of transplantation.

TL;DR: It is concluded that normalization of hematocrit in selected hemodialysis patients, i.e., nondiabetic patients without severe cardiovascular or cerebrovascular comorbidities, improves quality of life and decreases morbidity without significant adverse effects.

TL;DR: Quality of life in elderly patients improved as much as in younger patients, thereby fully justifying the use of EPO for the elderly, and final hematocrit was positively related to global SIP improvement.

TL;DR: Trait anxiety and depressive symptoms are strongly associated with the HRQOL assessed by the Kidney Disease Quality of Life Short-Form in HD patients, and the effects of these factors should therefore be considered when evaluating the quality of life of this type of patient.

TL;DR: In non-diabetic HD patients, aged < or = 65 yrs and with low comorbidity, psychological factors (anxiety state and depressive symptoms) are crucialHRQOL determinants and should be considered when assessing HRQOL in HD patients with these demographic and clinical characteristics.